首页|Fujian Cancer Hospital Reports Findings in Liver Cancer (Integrating anoikis and ErbB signaling insights with machine learning and singlecell analysis for pred icting prognosis and immune-targeted therapy outcomes in hepatocellular carcinom a)
Fujian Cancer Hospital Reports Findings in Liver Cancer (Integrating anoikis and ErbB signaling insights with machine learning and singlecell analysis for pred icting prognosis and immune-targeted therapy outcomes in hepatocellular carcinom a)
扫码查看
点击上方二维码区域，可以放大扫码查看
原文链接
NETL
NSTL
By a News Reporter-Staff News Editor at Robotics & Machine Learning DailyNews Daily News - New research on Oncology - Liver Cance r is the subject of a report. According to newsreporting originating from Fuzho u, People’s Republic of China, by NewsRx correspondents, research stated,“Hepat ocellular carcinoma (HCC) poses a significant global health challenge due to its poor prognosis andlimited therapeutic modalities. Anoikis and ErbB signaling p athways are pivotal in cancer cell proliferationand metastasis, but their relev ance in HCC remains insufficiently explored.”
FuzhouPeople’s Republic of ChinaAsiaCancerCarcinomasCyborgsEmerging TechnologiesHealth and MedicineLiver CancerMachine LearningOncologyTherapy
NETL
NSTL
